Sign in

CIK 0001360214

  • Large accelerated filer

HARROW, INC.

Sign in to watch
Ticker
HROW
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
450567010
Phone
+1 615-733-4731
Business address
1A BURTON HILLS BLVD, SUITE 200, NASHVILLE, TN
Former names
HARROW HEALTH, INC., Imprimis Pharmaceuticals, Inc., TRANSDEL PHARMACEUTICALS INC, Bywater Resources, Inc
  1. 4 Open-market sale Director sold 10,000 shares at $5.33 ($53,300)
  2. 4 Open-market sale Director sold 10,000 shares at $4.64 ($46,400)
  3. 3 Insider Initial Statement of Ownership
  4. 4 Open-market sale Director sold 10,000 shares at $4.21 ($42,100)
  5. 4 Open-market sale Director sold 10,000 shares at $3.00 ($30,000)
  6. 4 Open-market sale Director sold 10,000 shares at $3.00 ($30,000)
  7. 4 Open-market sale Director sold 130,000 shares at $3.00 ($390,000)
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 5 Insider Annual Insider Trading Report
  13. 4 Exercise or conversion Chief Commercial Officer acquired 30,000 shares (option exercise)
  14. 4 Exercise or conversion Chief Financial Officer acquired 30,000 shares (option exercise)
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Open-market sale Director sold 10,000 shares at $3.05 ($30,526)
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 9 of 15 · 296 filings